Inhibition of Malaria Parasite Invasion by Antibodies
Author Information
Author(s): Brian T Grimberg, Rachanee Udomsangpetch, Jia Xainli, Amy McHenry, Tasanee Panichakul, Jetsumon Sattabongkot, Liwang Cui, Moses Bockarie, Chetan Chitnis, John Adams, Peter A Zimmerman, Christopher L King
Primary Institution: The Center for Global Health and Diseases, Case Western Reserve University, Cleveland, Ohio, United States of America
Hypothesis
Antibodies directed against region two of P. vivax Duffy binding protein (PvDBPII) would inhibit P. vivax invasion of human erythrocytes.
Conclusion
Both rabbit and human antibodies directed against PvDBPII reduce the invasion efficiency of wild P. vivax isolated from infected patients, suggesting a potential PvDBP-based vaccine may reduce human blood-stage P. vivax infection.
Supporting Evidence
- Antibodies inhibited binding of rPvDBPII to the Duffy antigen N-terminal region.
- In vitro invasion assays showed that addition of rabbit anti-PvDBPII Ab reduced the number of parasite invasions by up to 64%.
- Pooled PvDBPII antisera from P. vivax–exposed people reduced P. vivax invasion by up to 54%.
Takeaway
Scientists found that special proteins from rabbits and humans can stop malaria germs from getting into red blood cells, which could help make a vaccine.
Methodology
Polyclonal antibodies were generated from immunized rabbits and affinity purified from the pooled sera of P. vivax–exposed Papua New Guineans, and their ability to inhibit P. vivax invasion was tested in vitro.
Limitations
The low number of parasites available from donor blood samples limited the number of conditions evaluated in the in vitro invasion-inhibition assays.
Participant Demographics
Participants included P. vivax–exposed Papua New Guineans and adult males from an endemic area along the Thailand/Myanmar border.
Statistical Information
P-Value
0.070
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website